Login / Signup

Safety and efficacy of different tirofiban administration routes on acute ischemic stroke patients with successful recanalization: A propensity score matching analysis.

Wenting GuoJiali XuLinqing MaJin MaSijie LiChanghong RenLongfei WuChuanjie WuChuanhui LiJian ChenJiangang DuanQingfeng MaHaiqing SongWenbo ZhaoXun-Ming Ji
Published in: CNS neuroscience & therapeutics (2022)
A low dose of tirofiban, regardless of their administration routes, was safe for AIS patients who achieved successful recanalization with EVT, whereas only IA + IV tirofiban improved clinical outcomes.
Keyphrases
  • acute ischemic stroke
  • low dose
  • middle cerebral artery
  • endovascular treatment
  • high dose